NHMRC Glaucoma Guidelines - ANZGIG
NHMRC Glaucoma Guidelines - ANZGIG
NHMRC Glaucoma Guidelines - ANZGIG
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>NHMRC</strong> GUIDELINES FOR THE SCREENING, PROGNOSIS, DIAGNOSIS, MANAGEMENT AND PREVENTION OF GLAUCOMA<br />
Table of contents<br />
Chapter 6 – Identifying those at risk of developing glaucoma 47<br />
Introduction 48<br />
Risk factors identified from patient history 50<br />
Risk factors identified through ocular examination 56<br />
Risk factors for specific glaucoma types and stages 59<br />
References 61<br />
Appendix to Chapter 6 63<br />
Chapter 7 – Diagnosis of glaucoma 65<br />
Introduction 65<br />
Diagnosis of glaucoma 67<br />
Medical history 67<br />
Risk factors 68<br />
Examination of eye structure 69<br />
Setting diagnostic baselines 72<br />
Examination of eye function 73<br />
Diagnosing specific glaucoma types 81<br />
Professional roles in diagnosis 83<br />
Summary of diagnostic standards 84<br />
Questions to ask patients with suspected glaucoma 86<br />
Questions to ask patients with established glaucoma 86<br />
What should I examine to identify open angle glaucoma? 86<br />
What should I examine to identify angle closure? 87<br />
References 88<br />
Chapter 8 – Monitoring: long-term care 91<br />
Introduction 91<br />
Medical history 92<br />
Intraocular pressure 93<br />
Eye structure examination 94<br />
Indications to change regimen 98<br />
Monitoring recommendations in specific populations 99<br />
Professional roles within the team 104<br />
Questions to ask your patient with glaucoma at review 105<br />
References 105<br />
Chapter 9 – Medication 107<br />
Introduction 107<br />
Hierarchies of intervention 108<br />
Starting medication regimens 110<br />
Facilitating adherence 111<br />
Medication interaction 113<br />
Side effects 115<br />
Topical medications 119<br />
Assessing medication efficacy 120<br />
Changing medication regimens 121<br />
Medication in acute angle closure crisis 121<br />
Addressing the impact of comorbidities 122<br />
Managing glaucoma successfully within specific comorbid conditions 124<br />
Managing glaucoma in specific population groups 129<br />
References 136<br />
iv<br />
National Health and Medical Research Council